🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, double-blind, randomized, placebo-controlled study t...
Status
Terminated
Location
Cara Therapeutics Study Site
Start Date
2022-05-17
Trial ID
NCT05342623
Treatments Being Tested
The primary purpose of this study is to determine if CR845 is effective in ...
Status
Completed
Location
Shoals Clinical Research Associates
Start Date
2011-07
Trial ID
NCT01361568
This is a single-center, randomized, double blind, placebo controlled, para...
Status
Completed
Location
Jean Brown Research
Start Date
2013-05
Trial ID
NCT01789476
The primary purpose of this study is to: * Evaluate the safety and pharmac...
Status
Completed
Location
US Renal Care
Start Date
2014-07
Trial ID
NCT02229929
This is a multicenter, randomized, double-blind, placebo-controlled study t...
Status
Terminated
Location
Cara Therapeutics Study Site
Start Date
2019-06-25
Trial ID
NCT03995212
Treatments Being Tested
This is a multicenter, open-label study to evaluate the safety and effectiv...
Status
Completed
Location
Cara Therapeutics Study Site
Start Date
2019-05-06
Trial ID
NCT03998163
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled study t...
Status
Completed
Location
Cara Therapeutics Study Site
Start Date
2021-01-11
Trial ID
NCT04706975
Treatments Being Tested
The purpose of this study is to determine the effectiveness and safety of s...
Status
Completed
Location
Mobile Infirmary Medical Center
Start Date
2009-03
Trial ID
NCT00877799
This is a Phase 1, randomized, double-blind (except for moxifloxacin), plac...
Status
Completed
Location
Cara Therapeutics Study Site
Start Date
2019-06-20
Trial ID
NCT04019574
Treatments Being Tested
This is a multicenter, double-blind, randomized, placebo-controlled study t...
Status
Terminated
Location
Cara Therapeutics Study Site
Start Date
2022-08-26
Trial ID
NCT05356403
Treatments Being Tested